DUBLIN , Dec. 29, 2021 /PRNewswire/ -- The "Implantable Infusion Pumps Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering.
Executive Summary: The global implantable infusion pumps market is expected to decline from $16.21 billion in 2020 to $15.15 billion in 2021 at a compound annual growth rate (CAGR) of -6.6%.
The decline in the market is mainly due to the companies decreasing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $19.03 billion in 2025 at a CAGR of 6%. The implantable infusion pumps market consists of sales of implantable infusion pumps and related services by entities (organizations, sole traders and partnerships) that manufacture implantable infusion pumps.
An implantable infusion pump is a small device that is put beneath the skin during the operation. The pump delivers the liquid pain medication to a different part of the body through a long, flexible tube called the catheter. The implantable infusion pumps market by type into patient-controlled analgesia (PCA) pumps, enteral pumps, insulin pumps, elastomeric pumps, syringe pumps, others; applications into oncology, pediatrics/neonatology, gastroenterology, hematology, diabetes, others. The regions covered in this report are Asia-Pacific , Western Europe , Eastern Europe , North America , South America , Middle East and Africa . The safety concern regarding implantable infusion pumps is a key factor hampering the growth of the implantable infusion pumps market. The magnetic resonance (MR) system can be useful in the diagnosis of a wide range of conditions and diseases, but the MRI setting poses a risk factor for patients with implantable infusion pumps.
An MRI examination can influence the programming or functionality of an infusion pump, even if specific requirements have been met. In 2018, the US food and drug administration received evidence of significant adverse effects including harm to the patient and death associated with the use of implantable infusion pumps in the MR field.
Therefore, the safety concerns regarding implantable infusion pumps is expected to limit the growth of the implantable infusion pumps market. The increased prevalence of people with chronic pain, cancer and diabetes is expected to drive the demand for implantable infusion pumps, as these pumps are commonly used to deliver pharmaceutical drugs during the treatment of these diseases.
Chronic illnesses and disorders are on the rise around the world, as the aging population and shifts in social behavior lead to a gradual increase in these diseases. In diseases such as chronic arachnoiditis, which is a condition where one of the membranes surrounding the spinal cord swells, implantable infusion pumps deliver lower dosages of drugs and tend to provide more efficient pain relief.
The prevalence of chronic diseases is expected to increase by 57% by 2020, according to the World Health Organization. Therefore, the rise in the prevalence of chronic diseases is expected to drive the growth of the implantable infusion pumps market. Companies in the implantable infusion pump market are increasingly focusing on developing smart infusion pumps. The use of wireless technology in the health monitoring devices is increasing, which enhances the ease of usage, connectivity and data analysis.
The integration of wireless technology allows the transfer of data from the device to a smartphone or a wireless device through Bluetooth or cellular connection for data processing and then to display the results, which can be used for further study and to check the health condition of the individual.
Software platforms are being developed that allow patient monitoring and reduce human error. In June 2019 , Ivenix, a US-based medical device company, received clearance for a new smart infusion pump, which reduces human and software error with more streamlined technology. The countries covered in the market report are Australia , Brazil , China , France , Germany , India , Indonesia , Japan , Russia , South Korea , UK, USA . Companies Mentioned
Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/b4t63f
Research and Markets Laura Wood , Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716
View original content:https://www.prnewswire.com/news-releases/global-implantable-infusion-pumps-market-expected-to-reach-19-billion-by-2025-301451451.html
What happened Shares of Novavax (NASDAQ: NVAX) were slipping 2.6% lower as of 11:35 a.m. ET on Wednesday. The company didn't report any new developments since yesterday's announcement that India had granted Emergency Use Authorization (EUA) to COVID-19 vaccine NVX-CoV2373.
Altcoins posted a mixed performance as the crypto market declined ahead of a major options expiry for bitcoin on Friday.
Gas prices are likely headed much higher in 2022, according to a new report out of Gasbuddy.
Ford Motor Co. is preparing to make its largest play yet into the world of electric vehicles. Here's how it's considering its expansion in Kentucky.
(Bloomberg) -- Aluminum rose as investors weighed fresh signs of pressure on output, with Alcoa Corp. planning to shut a European plant and Beijing vowing to cut carbon emissions from China’s huge army of smelters.Most Read from BloombergGhislaine Maxwell Found Guilty in Win for Epstein VictimsMercedes Swept Up in China Internet Furor Over Models’ EyesApple Aims to Prevent Defections to Meta With Rare $180,000 Bonuses for Top TalentThe Senator Who Could Rescue Biden’s AgendaCovid With Omicron Is
Yahoo Finance's Rick Newman details which CEOs have been recorded to have met with President Biden the most in 2021 as the administration has worked to try and curtail concerns over inflation, supply chain issues, and retailer worries.
Oil prices are affected by myriad factors. Here are three things that could impact oil prices and oil stocks in 2022.
Yahoo Finance contributor Vera Gibbons details how the pandemic has changed the secondhand clothing market, the overflow of consigned clothes leading to markdowns, and how that trend continues heading into 2022.
(Bloomberg) -- China’s securities regulator rebuked China International Capital Corp., saying the country’s top investment bank has failed in due diligence on Lenovo Group Ltd.’s recent application for a $1.6 billion stock listing in Shanghai.Most Read from BloombergGhislaine Maxwell Found Guilty in Win for Epstein VictimsMercedes Swept Up in China Internet Furor Over Models’ EyesApple Aims to Prevent Defections to Meta With Rare $180,000 Bonuses for Top TalentThe Senator Who Could Rescue Biden’
The natural gas markets have rallied again during the day on Wednesday, reaching towards the 200 day EMA yet again. That being said, we are still very much in consolidation.
Illumina develops and manufactures various life science tools. According to the company's website the company's mission is to improve human health by unlocking the power of the genome. Let's see what kind of power we can unlock by looking at the charts.
HSBC said on Thursday it had received regulatory approval in China to take full ownership of its life insurance joint venture in the country, as it continues to expand its non-core banking services. HSBC has got clearance from the Shanghai office of the China Banking and Insurance Regulatory Commission to buy the remaining 50% in its venture HSBC Life China, the bank said. HSBC first agreed the deal in May 2020 in order to fully own the company to comply with China's rules on foreign ownership of insurance companies.
Airlines such as Delta Air Lines and Alaska Air Group have canceled hundreds of flights, while the surge in new infections has also threatened to derail a recovery in the cruise industry. The event, starting Jan. 5, will require all attendees to be masked and vaccinated, and also offer COVID-19 tests, a spokesperson for Consumer Technology Association, the event organizer, said. Several others, including U.S. automaker General Motors Co, Alphabet Inc's Google, Facebook parent Meta Platforms Inc, Twitter Inc, Lenovo Group, AT&T Inc and Amazon.com Inc have dropped their in-person attendance plans, saying they would not send employees out of caution over the spread of Omicron.
Abu Dhabi ramps up effort to become Middle East’s crypto hub by regulating digital asset exchanges.
The Thai cryptocurrency mining sector has experienced massive growth in recent months, thanks to China’s ban on crypto mining activities.
Cipher Mining CEO Tyler Page joins Yahoo Finance Live to discuss the 2022 outlook for bitcoin mining, difficulties in mining cryptocurrencies, and the mining firm's business model that allows it to compete in that space.
(Bloomberg) -- China’s government cut the amount of crude oil import quota awarded to independent oil refiners and favored large, complex processors as it seeks to reform the sector.Most Read from BloombergGhislaine Maxwell Found Guilty in Win for Epstein VictimsMercedes Swept Up in China Internet Furor Over Models’ EyesApple Aims to Prevent Defections to Meta With Rare $180,000 Bonuses for Top TalentThe Senator Who Could Rescue Biden’s AgendaCovid With Omicron Isn’t ‘Same Disease,’ Oxford Scien
(Bloomberg) -- The rapid spread of omicron has yet to dampen road traffic across most of Asia even as it leads to restrictions in parts of Europe, suggesting energy demand in the region may be spared a significant hit.Most Read from BloombergGhislaine Maxwell Found Guilty in Win for Epstein VictimsMercedes Swept Up in China Internet Furor Over Models’ EyesApple Aims to Prevent Defections to Meta With Rare $180,000 Bonuses for Top TalentThe Senator Who Could Rescue Biden’s AgendaCovid With Omicro
Crude oil futures finish solidly higher Wednesday after data show a big drop in U.S. crude inventories.
China's factory activity likely neither grew nor shrunk in December, a Reuters poll showed, amid disruptions from COVID-19 outbreaks and as the economy lost momentum in the fourth quarter. "We expect NBS manufacturing PMI to moderate to 49.9 in December from 50.1 in November," said analysts at Goldman Sachs in a note this week, referring to the National Bureau of Statistics. The wealthy Zhejiang province, on China's eastern coast, saw a small-scale COVID-19 outbreak earlier this month, which has now subsided.